GRI’s common stock is expected to begin trading on a post-split adjusted basis on February 24, 2025LA JOLLA, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) ...

A surprising sighting of rare black wolves in Poland has sparked curiosity among scientists and conservationists. These ...

Participants will don purple and white T-shirts as a symbol of unity and support for those living with lupus. Event attendees can also visit the Lupus Warriors Stall to learn more about the ...

GRI's common stock is expected to begin trading on a post-split adjusted basis on February 24, 2025 LA JOLLA, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or the "Compa ...

Make Valentine’s Day memorable with these 5 unique date ideas inspired by the ocean—perfect for celebrating love in all its ...

Lupus involves unpredictable symptom flares and potential changes in brain chemistry that may increase your risk of experiencing depression and anxiety. Lupus is a chronic (long-term) autoimmune ...

July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...

Historically, lupus caused people to die young. But today, most people with lupus have a typical life expectancy with treatment. Frequency of flares and complications may influence your outlook ...

Patient enrollment is ongoing in the Phase 1 study of ADI-001 for the treatment of lupus nephritis (LN). Patient enrollment in SLE, systemic sclerosis (SSc), idiopathic inflammatory myopathy ...

Over 55,000 Georgians are living with lupus. Whether you are living with lupus or loving someone with lupus, we are here. We'll be starting off at the Central Presbyterian Church across the street ...

Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing Charles River's immunology expertise to refine study paramet ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...